Pharmacokinetics of Ciprofloxacin in Hospitalized Geriatric Patients: Comparison Between Nasogastric Tube and Oral Administration

被引:8
作者
Lubart, Emily [1 ]
Berkovitch, Matitiahu [2 ]
Leibovitz, Arthur [1 ]
Britzi, Malka [3 ]
Soback, Stefan [3 ]
Bukasov, Yury [1 ]
Segal, Rafael [1 ]
机构
[1] Shmuel Harofeh Med Ctr, Dept Geriatr, IL-70300 Beer Yaacob, Israel
[2] Tel Aviv Univ, Clin Pharmacol Unit, Assaf Harofeh Med Ctr, Sackler Sch Med, Bet Dagan, Israel
[3] Minist Agr, Natl Residue Control Lab, Kimron Vet Inst, Bet Dagan, Israel
关键词
ciprofloxacin concentration; nasogastric tube; orally fed; geriatric patients; therapeutic drug monitoring; CRITICALLY-ILL PATIENTS; VOLUNTEERS; ABSORPTION; SUSPENSION; DECISIONS; PNEUMONIA; LIFE; HOME;
D O I
10.1097/FTD.0b013e3182940426
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives:Drug administration to debilitated elderly patients on enteral feeding through a nasogastric tube (NGT) can modify the pharmacokinetic characteristics of the drug and influence its therapeutic blood concentration. The aim of this study was to evaluate the pharmacokinetics of ciprofloxacin administered through an NGT and to compare it with those of a group of patients receiving the drug orally.Methods:Twenty patients in stable clinical and hemodynamic condition from the long-term care ward of a geriatric multilevel hospital were studied. Patients in group 1 (n = 10) had oropharyngeal dysphagia and received food and medications, including ciprofloxacin, by NGT. Group 2 (n = 10) included age- and disease-matched orally fed patients from the same department receiving ciprofloxacin orally. Blood samples for ciprofloxacin concentration were taken at steady state, before drug administration, time 0, and at 1, 2, 3, 4, 6, 8, and 10 hours after drug administration. Ciprofloxacin was measured using liquid chromatography with tandem mass spectrometric detection. The mean daily dose was the same in both the groups: 1000 mg (500 mg twice daily).Results:Pharmacokinetic parameters of ciprofloxacin were not significantly different between the 2 groups: trough concentrations were 1.24 0.95 g/mL (0.25-3.67 g/mL) versus 1.30 +/- 0.61 g/mL (0.21-2.36 g/mL) (P = 0.76); C-max 3.30 +/- 2.16 g/mL (1.54-8.62 g/mL) versus 4.24 +/- 1.99 g/mL (2.24-9.02 g/mL) (P = 0.356); t(max) 2.8 +/- 1.5 versus 3.1 +/- 2.8 hours (P = 0.799); and AUC(0-10) 20.2 +/- 12.1 gh(-1)mL(-1) (9-51.07 gh(-1)mL(-1)) versus 24.4 +/- 13.0 gh(-1)mL(-1) (5.57-52.48 gh(-1)mL(-1)) (P = 0.493), in the oral fed versus NGT, respectively.Conclusions:Ciprofloxacin pharmacokinetic parameters are not significantly different between patients receiving the drug through NGT compared with those who received it orally, and therefore, in frail elderly patients, this route of administration can be considered.
引用
收藏
页码:653 / 656
页数:4
相关论文
共 30 条
[1]   The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing [J].
Begg, EJ ;
Robson, RA ;
Saunders, DA ;
Graham, GG ;
Buttimore, RC ;
Neill, AM ;
Town, GI .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (01) :32-38
[2]  
Belknap D C, 1997, Am J Crit Care, V6, P382
[3]  
Bergan T., 1988, QUINOLONES, P119
[4]   Therapeutic drug monitoring of theophylline in frail elderly patients: Oral compared with nasogastric tube administration [J].
Berkovitch, M ;
Dafni, O ;
Leiboviz, A ;
Mayan, H ;
Habut, B ;
Segal, R .
THERAPEUTIC DRUG MONITORING, 2002, 24 (05) :594-597
[5]  
BRITTAIN DC, 1985, DRUG EXP CLIN RES, V11, P339
[6]  
CIOCON J O, 1990, Dysphagia, V5, P1, DOI 10.1007/BF02407387
[7]  
Cohn SM, 1996, J ANTIMICROB CHEMOTH, V38, P871
[8]   Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: A comparison of two dosages [J].
Debon, R ;
Breilh, D ;
Boselli, E ;
Saux, MC ;
Duflo, F ;
Chassard, D ;
Allaouchiche, B .
JOURNAL OF CHEMOTHERAPY, 2002, 14 (02) :175-180
[9]  
Dickerson RN, 2004, HOSP PHARM, V39
[10]   TREATMENT OF SEVERE PNEUMONIA IN HOSPITALIZED-PATIENTS - RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING INTRAVENOUS CIPROFLOXACIN WITH IMIPENEM-CILASTATIN [J].
FINK, MP ;
SNYDMAN, DR ;
NIEDERMAN, MS ;
LEEPER, KV ;
JOHNSON, RH ;
HEARD, SO ;
WUNDERINK, RG ;
CALDWELL, JW ;
SCHENTAG, JJ ;
SIAMI, GA ;
ZAMECK, RL ;
HAVERSTOCK, DC ;
REINHART, HH ;
ECHOLS, RM ;
HELSMOORTEL, C ;
SOJASTRZEPA, D ;
SCHWAITZBERG, S ;
BAREFOOT, L ;
FEIN, AM ;
FEINSILVER, SH ;
ILOWITE, JS ;
CLARE, N ;
SCHULMAN, D ;
JONES, CB ;
GRIFFIN, RI ;
WROBEL, CW ;
BALLOW, CH ;
AMSDEN, G ;
MITCHELL, P ;
BESS, T ;
WILKINS, W ;
BROWN, RB ;
MCGEE, W ;
SAFFORD, MJ ;
LEVINE, DP ;
LERNER, SA ;
KRUSE, JA ;
BANDER, JJ ;
MCNEIL, P ;
MUNKARAH, M ;
SUMMER, WR ;
DEBOISBLANC, B ;
LEVISON, ME ;
KORZENIOWSKI, O ;
SIGLER, A ;
BALDASSARRE, J ;
WALSH, P ;
SAMEL, C ;
SESSLER, CN ;
POLK, RE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :547-557